| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
198,230,000 |
| Market
Cap: |
32.11(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.162 - $0.162 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing therapies to treat the whole eye. Co.'s gene therapy candidate includes: OCU400, which is used for the treatment of nuclear receptor subfamily 2 group E member 3 mutation-associated retinal diseases and centrosomal protein 290 mutation-associated retinal diseases; OCU410, which is being developed for the treatment of dry age-related macular degeneration (AMD); OCU200, which is designed to treat diabetic macular edema, diabetic retinopathy and wet AMD; and OCU300, which is a small molecule therapeutic in clinical development for patients with ocular graft-versus-host disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
200,278 |
200,278 |
| Total Buy Value |
$0 |
$0 |
$99,999 |
$99,999 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
599,809 |
| Total Sell Value |
$0 |
$0 |
$0 |
$1,096,737 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
8 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Split Rock Partners Ii Management, Llc |
10% Owner |
– – • |
2016-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,114,043 |
2,775,538 |
|
- |
|
| Gill David N |
Director |
– • – |
2016-12-09 |
4 |
B |
$1.92 |
$9,600 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Lewis Michael |
Director |
– • • |
2016-12-02 |
4 |
A |
$0.00 |
$0 |
I/I |
996,779 |
3,072,110 |
|
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2016-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
996,779 |
3,072,110 |
|
- |
|
| Lieber Jonathan I |
Chief Financial Officer |
• – – |
2016-12-02 |
4 |
B |
$1.95 |
$9,731 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Gridley Adam |
President and CEO |
• • – |
2016-12-01 |
4 |
B |
$2.01 |
$10,040 |
D/D |
5,000 |
5,000 |
2.81 |
- |
|
| Rakin Kevin |
Director |
– • – |
2016-11-30 |
4 |
A |
$0.00 |
$0 |
I/I |
142,396 |
228,196 |
|
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2016-09-29 |
4 |
A |
$2.25 |
$557,246 |
D/D |
247,665 |
2,075,331 |
|
- |
|
| Rakin Kevin |
Director |
– • – |
2016-09-29 |
4 |
A |
$2.25 |
$79,607 |
I/I |
35,381 |
85,800 |
|
- |
|
| Lewis Michael |
Director |
– • • |
2016-09-29 |
4 |
A |
$2.25 |
$557,246 |
I/I |
247,665 |
2,075,331 |
|
- |
|
| Split Rock Partners Ii Management, Llc |
10% Owner |
– – • |
2016-09-29 |
4 |
B |
$2.25 |
$622,802 |
D/D |
276,801 |
1,661,495 |
2.45 |
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2015-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(89,441) |
1,827,666 |
|
- |
|
| Lewis Michael |
Director |
– • • |
2015-06-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(89,441) |
1,827,666 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2014-12-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,690,570 |
|
- |
|
| Mehra Anand |
10% Owner |
– – • |
2014-12-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,808) |
2,077,040 |
|
- |
|
| Mehra Anand |
10% Owner |
– – • |
2014-12-08 |
4 |
B |
$11.00 |
$5,502,178 |
I/I |
500,198 |
2,085,848 |
1.5 |
- |
|
| Mehra Anand |
10% Owner |
– – • |
2014-12-08 |
4 |
S |
$11.00 |
$11,022 |
I/I |
(1,002) |
1,585,650 |
|
- |
|
| Mehra Anand |
10% Owner |
– – • |
2014-12-08 |
4 |
OE |
$0.76 |
$11,072 |
I/I |
14,569 |
1,586,652 |
|
- |
|
| Mehra Anand |
10% Owner |
– – • |
2014-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
1,572,083 |
1,572,083 |
|
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2014-12-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,383) |
1,917,107 |
|
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2014-12-08 |
4 |
B |
$11.00 |
$4,344,098 |
D/D |
394,918 |
1,934,490 |
2.45 |
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2014-12-08 |
4 |
S |
$11.00 |
$8,712 |
D/D |
(792) |
1,539,572 |
|
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2014-12-08 |
4 |
OE |
$0.76 |
$8,742 |
D/D |
11,502 |
1,540,364 |
|
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2014-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,239,618 |
1,528,862 |
|
- |
|
| Rakin Kevin |
Director |
– • – |
2014-12-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(58) |
50,420 |
|
- |
|
195 Records found
|
|
Page 7 of 8 |
|
|
